Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivus Inc VVUSQ

Healthcare Biotechnology
VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic... see more

Recent & Breaking News (OTCPK:VVUSQ)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of VIVUS Inc. - VVUS

PR Newswire May 17, 2016

Osaki Chooses MegaChips Multi-hop Technology for Improved Energy Management

PR Newswire May 17, 2016

Shareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating VIVUS, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

PR Newswire May 16, 2016

Vivus Reports 2016 First Quarter Financial Results

MarketWire Canada May 3, 2016

VIVUS Announces Date of 2016 First Quarter Business Update and Financial Results Teleconference

Marketwired April 19, 2016

VIVUS Reports Fourth Quarter and Year-End 2015 Financial Results

Marketwired March 9, 2016

VIVUS Announces Date of Fourth Quarter 2015 Update and Financial Results Teleconference

Marketwired February 29, 2016

VIVUS, Inc. Announces Intent to Reacquire U.S. and Canadian Rights for Stendra(R) (Avanafil)

Marketwired December 31, 2015

A New Take On New Year's And Chronic Weight Management: Smart Changes(TM) Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss

PR Newswire December 29, 2015

A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss

Press Releases December 29, 2015

Trading Ahead of Upcoming Developments - Research on Vivus, ReneSola, Consumer Portfolio Services and BioScrip

Accesswire November 23, 2015

VIVUS Reports Third Quarter 2015 Financial Results

Marketwired November 4, 2015

VIVUS Announces Qsymia Presentations at Obesity Week 2015

Marketwired November 3, 2015

VIVUS Announces Date of Third Quarter 2015 Update and Financial Results Teleconference

GlobeNewswire October 28, 2015

VIVUS, Inc. Board of Directors Expresses No Opinion and Remains Neutral Toward Icahn Group's Unsolicited Offer to Purchase 4.50% Convertible Senior Notes

Marketwired September 22, 2015

Icahn Offer Considered - Critical Information for Vivus Shareholders

Accesswire September 10, 2015

VIVUS Reports Second Quarter 2015 Financial Results

Marketwired July 30, 2015

VIVUS Reports Second Quarter 2015 Financial Results

Marketwired July 30, 2015

VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call

GlobeNewswire July 23, 2015

VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call

GlobeNewswire July 23, 2015